Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 2 3Phase 4 1Phase 2/3 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Liver Diseases 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Interventional × fluorocholine × Clear all
NCT05622162 2024-05-22

MIP7

ITEL Telecomunicazioni Srl

Phase 3 Active not recruiting
106 enrolled
Genitourinary

Prostatic Neoplasms

NCT02840552 2018-08-09

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

Sir Mortimer B. Davis - Jewish General Hospital

Phase 3 Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡